Abstract PR010: Targeted degradation of cyclin T1 constrains transcription elongation and triggers tumour cell apoptosis
Transcriptional dysregulation is a hallmark of cancer and is frequently driven by oncogenic alterations that rewire downstream gene-expression programmes. Although kinase inhibitors targeting upstream oncogenic drivers can produce clinical benefit, responses are often limited by acquired resistance and pathway adapta...